Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Oragenics Inc (NYSE MKT LLC:OGEN)

0.84
Delayed Data
As of 3:57pm ET
 +0.0316 / +3.91%
Today’s Change
0.66
Today|||52-Week Range
3.87
-44.00%
Year-to-Date
No recent news for Oragenics Inc.

Today’s Trading

Previous close0.81
Today’s open0.86
Day’s range0.83 - 0.90
Volume6,144
Average volume (3 months)37,144
Market cap$29.5M
Dividend yield--
Data as of 3:57pm ET, 02/12/2016

Growth & Valuation

Earnings growth (last year)+71.43%
Earnings growth (this year)-131.25%
Earnings growth (next 5 years)--
Revenue growth (last year)-8.94%
P/E ratioNM
Price/Sales34.22
Price/Book2.83

Competitors

 Today’s
change
Today’s
% change
HEBHemispherx Biopharma...+0.00+2.55%
VICLVical Inc-0.01-4.69%
STDYSteadymed Ltd+0.14+6.48%
BLPHBellerophon Therapeu...-0.18-8.14%
Data as of 3:59pm ET, 02/12/2016

Financials

Last reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$939.9K
Annual profit (last year)-$5.8M
Net profit margin-615.95%

Profile

Sector
Health Technology
Industry
Biotechnology
CEO, CFO, Secretary &
Treasurer
Michael O'Keefe Sullivan
Senior Vice President-
Discovery Research
Martin Handfield
Corporate headquarters
Tampa, Florida

Forecasts

Partner Offers